WHO ICTRP trial
Effect of gomutra plus capsule on primary obesity double blind placebo control…
CTRI/2023/04/051595 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/04/051595 |
|---|---|
| Public title | Effect of gomutra plus capsule on primary obesity double blind placebo control trial- POST MARKETTING SURVILLENCE |
| Scientific title | A Randomised Double Blind Placibo Controlled Clinical Trial To Evaluate Efficacy Of Gomutra Plus Capsule On Obesity |
| Primary sponsor | PITAMBARI PRODUCTS PRIVATE LIMITED |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: K928- Other specified diseases of the digestive system |
| Registration date | Apr 13, 2023 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: